Litigation Details for Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-03-26 |
| Court | District Court, D. Delaware | Date Terminated | 2022-08-10 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | ALVOGEN PB RESEARCH AND DEVELOPMENT LLC | ||
| Patents | 10,314,828; 10,335,397; 10,456,384; 6,861,053; 7,045,620; 7,417,042; 7,612,199; 7,737,112; 7,902,206; 7,906,542; 7,915,275; 7,928,115; 8,158,644; 8,158,781; 8,193,196; 8,207,125; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,023,001; 9,023,417; 9,271,968; 9,421,195; 9,623,001; 9,629,828 | ||
| Attorneys | Ricardo S. Camposanto | ||
| Firms | JPMorgan Chase & Co. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-26 | 1 | Complaint | (the “’9,828 patent”); 10,314,828 (the “’4,828 patent”); 10,335,397 (the “’397 patent”); and 10,456,…; 8,969,398; 9,271,968; 9,421,195; 9,629,828; 10,314,828; 10,335,397; and 10,456,384 by submitting ANDA…; 8,969,398; 9,271,968; 9,421,195; 9,629,828; 10,314,828; 10,335,397; and 10,456,384 under 35 U.S.C. … 8,969,398; 9,271,968; 9,421,195; 9,629,828; 10,314,828; 10,335,397; and 10,456,384 remain valid and … 8,969,398; 9,271,968; 9,421,195; 9,629,828; 10,314,828; 10,335,397; and 10,456,384, inclusive of any | External link to document |
| 2021-08-03 | 118 | Notice of Service | the Invalidity of U.S. Patent Nos. 8,642,573; 8,969,398; 9,421,195; 10,335,397; and 10,709,694 4. Opening…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 2. Opening Expert of Michael J. Zaworotko…Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542…2020 10 August 2022 1:20-cv-00430 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-10-19 | 138 | Notice of Service | Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 (3)…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 (7) Responsive Expert Report of Richard…Regarding Noninfringement of Claims 9 and 10 of U.S. Patent No. 7,906,542 filed by Norwich Pharmaceuticals …2020 10 August 2022 1:20-cv-00430 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-03-08 | 153 | Proposed Pretrial Order | (the “’9,828 Patent”); 10,314,828 (the “’4,828 Patent”); 10,335,397 (the “’397 Patent”); 10,456,384 …the Polymorph Patents, the IBS-D Patents, and the HE Patents make up the “Asserted Patents.” 2 See Section… United States Patent Nos. 7,045,620 (the “’620 Patent”); 7,612,199 (the “’199 Patent”); 7,902,206 (the…(the “’206 Patent”); 7,906,542 (the “’542 Patent”); 7,915,275 (the “’275 Patent”); 8,158,644 (the “’644…’644 Patent”); 8,158,781 (the “’781 Patent”); 8,193,196 (the “’196 Patent”); 8,309,569 (the “’569 Patent | External link to document |
| 2022-03-31 | 167 | 8,309,569 (“the ’569 patent”) and 9,421,195 (“the ’195 patent”); and 10,335,397 … Patents / Claim Numbers ’573 Patent ’195 Patent … Patents / Claim Numbers ’573 Patent ’195 Patent … Patents / Claim Numbers ’573 Patent ’195 Patent … Patents / Claim Numbers ’573 Patent ’195 Patent | External link to document | |
| 2022-04-28 | 174 | POST Trial Brief | ’206 patent U.S. Patent No. 7,902,206 ’397 patent U.S. Patent No. 10,335,397 ’569 patent…ABBREVIATIONS ’195 patent U.S. Patent No. 9,421,195 ’199 patent U.S. Patent No. 7,612,199 … U.S. Patent No. 8,309,569 ’573 patent U.S. Patent No. 8,642,573 ’667 patent U.S. Patent… ’195 patent, claim 6; and ’397 patent, claims 11 and 12; (2) IBS-D Patent Claims: ’569 patent, claim…and ’667 patent, claim 3; and (3) Polymorph Patent Claims: ’199 patent, claim 4 and ’206 patent, claim | External link to document |
| 2022-04-28 | 176 | POST Trial Brief | ’667 patent Patents-in-Suit The ’199 patent, ’206 patent, ’573 patent, …States Patent No. 7,902,206 Polymorph Patents The ’199 patent and ’206 patent Asserted…10,335,397 HE Patents The ’573 patent, ’195 patent, and ’397 patent Asserted… ’195 patent, ’397 patent, ’569 patent and ’667 patent POSA …diarrhea ’199 patent JTX2 United States Patent No. 7,612,199 ’206 patent | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
